↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Tyck till om SwePub Sök här!

Träfflista för sökning "WFRF:(Blennow K) srt2:(2005-2009)"

Sökning: WFRF:(Blennow K) > (2005-2009)

Resultat 1-10 av 52

Sortera/gruppera träfflistan

Sortering: Träffar per sida:

Numrering	Referens	Omslagsbild	Hitta
1.	Blennow, M, et al. (författare) HIGH ONE-YEAR SURVIVAL AFTER ACTIVE PERINATAL CARE : EXTREMELY PRETERM INFANTS IN SWEDEN (EXPRESS) 2009 Ingår i: in ACTA PAEDIATRICA, vol 98. ; , s. 8-8 Konferensbidrag (refereegranskat)abstract n/a
2.	Imreh, MP, et al. (författare) In vitro culture conditions favoring selection of chromosomal abnormalities in human ES cells 2006 Ingår i: Journal of cellular biochemistry. - : Wiley. - 0730-2312 .- 1097-4644. ; 99:2, s. 508-516 Tidskriftsartikel (refereegranskat)
3.	Buerger, K, et al. (författare) Phosphorylated tau predicts rate of cognitive decline in MCI subjects: a comparative CSF study. 2005 Ingår i: Neurology. - : Ovid Technologies (Wolters Kluwer Health). - 1526-632X .- 0028-3878. ; 65:9, s. 1502-3 Tidskriftsartikel (refereegranskat)
4.	Gertow, K, et al. (författare) Trisomy 12 in HESC leads to no selective in vivo growth advantage in teratomas, but induces an increased abundance of renal development 2007 Ingår i: Journal of cellular biochemistry. - : Wiley. - 0730-2312 .- 1097-4644. ; 100:6, s. 1518-1525 Tidskriftsartikel (refereegranskat)
5.	Höglund, Kina, 1976, et al. (författare) The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease 2005 Ingår i: Dementia and Geriatric Cognitive Disorders. - : S. Karger AG. - 1420-8008 .- 1421-9824. ; 19:5-6, s. 256-265 Tidskriftsartikel (refereegranskat)abstract During the last years, several clinical studies have been published trying to elucidate the effect of statin treatment on amyloid precursor protein (APP) processing and metabolism of brain cholesterol in Alzheimer’s disease (AD) in humans. We present an open biochemical study where 19 patients with AD have been treated with simvastatin (20 mg/day) for 12 months. The aim was to further investigate the effect of simvastatin treatment on cerebrospinal fluid (CSF) biomarkers of APP processing, AD biomarkers as total tau and tau phosphorylated at threonine 181, brain cholesterol metabolism as well as on cognitive decline in patients with AD. Despite biochemical data suggesting that treatment with 20 mg/day of simvastatin for 12 months does affect the brain cholesterol metabolism, we did not find any change in CSF or plasma levels of β-amyloid (Aβ)<sub>1–42</sub>. However, by analysis of APP isoforms, we found that statin treatment may favor the nonamyloidogenic pathway of APP processing. The relevance and mechanism between statin treatment and AD has to be further elucidated by using statins of different lipophility in different dosages over a longer period of time.
6.	Lindstrom, K, et al. (författare) Moderate neonatal encephalopathy: pre- and perinatal risk factors and long-term outcome 2008 Ingår i: Acta obstetricia et gynecologica Scandinavica. - : Wiley. - 1600-0412 .- 0001-6349. ; 87:5, s. 503-509 Tidskriftsartikel (refereegranskat)
7.	Solberg, S, et al. (författare) Storm and forest damage: the risk of storm damage in forests, and the importance of forest management 2008 Rapport (övrigt vetenskapligt/konstnärligt)
8.	Wiltfang, J., et al. (författare) Consensus Paper of the WFSBP Task Force on Biological Markers of Dementia : The role of CSF and blood analysis in the early and differential diagnosis of dementia 2009 Ingår i: Revista de Psiquiatria Clinica. - 0101-6083. ; 36, s. 1-16 Forskningsöversikt (refereegranskat)abstract Aging of population, and increasing life expectancy result in an increasing number of patients with dementia. This symptom can be a part of a completely curable disease of the central nervous system (e.g, neuroinflammation), or a disease currently considered irreversible (e.g, Alzheimer's disease, AD). In the latter case, several potentially successful treatment approaches are being tested now, demanding reasonable standards of pre-mortem diagnosis. Cerebrospinal fluid and serum analysis (CSF/serum analysis), whereas routinely performed in neuroinflammatory diseases, still requires standardization to be used as an aid to the clinically based diagnosis of AD. Several AD-related CSF parameters (total tau, phosphorylated forms of tau, A beta peptides, ApoE genotype, p97, etc.) tested separately or in a combination provide sensitivity and specificity in the range of 85%, the figure commonly expected from a good diagnostic tool. In this review, recently published reports regarding progress in neurochemical pre-mortem diagnosis of dementias are discussed with a focus on an early and differential diagnosis of AD. Novel perspectives offered by recently introduced technologies, e.g, fluorescence correlation spectroscopy (FCS) and surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) are briefly discussed.
9.	Andersson, C, et al. (författare) Tau and A beta 42 levels in cerebrospinal fluid correlate with verbal episodic memory function according to Rey Auditory Verbal Learning Test and are significantly associated with the number of APOE epsilon 4 alleles - Preliminary results 2005 Ingår i: INTERNATIONAL PSYCHOGERIATRICS. - 1041-6102. ; 17, s. 160-161 Konferensbidrag (övrigt vetenskapligt/konstnärligt)
10.	Andreasen, N, et al. (författare) Cerebrospinal fluid levels of tau, phophorylated-tau, and amyloid beta 1-42 in subjects with MCI 2005 Ingår i: INTERNATIONAL PSYCHOGERIATRICS. - 1041-6102. ; 17, s. 22-23 Konferensbidrag (övrigt vetenskapligt/konstnärligt)

Skapa referenser, mejla, bekava och länka

Länka till träfflistan

Resultat 1-10 av 52

Avgränsa träffmängd

Typ av publikation: tidskriftsartikel (32); konferensbidrag (13); forskningsöversikt (5); rapport (1); bokkapitel (1)

Typ av innehåll: refereegranskat (42); övrigt vetenskapligt/konstnärligt (9); populärvet., debatt m.m. (1)

Författare/redaktör: Blennow, Kaj, 1958 (17); Blennow, K (10); Blennow, M. (7); Blennow, E (6); Andreasen, N (5); Vanderstichele, H (5); visa fler...; Wallin, Anders, 1950 (4); Scheltens, P (4); Vanmechelen, E (4); Hampel, H. (4); Zetterberg, H. (3); Gubanski, Stanislaw, ... (3); Forestier, Erik (3); Johansson, Bertil (3); Heim, Sverre (3); Wallenberg, Reine (3); Gertow, K (3); AHRLUND-RICHTER, L (3); Wiltfang, J (3); Golovleva, Irina (3); Andersen, Mette K. (3); Autio, Kirsi (3); Hovland, Randi (3); Johannsson, Johann H ... (3); Nordgren, Ann (3); Blennow, Elisabeth (3); Walczak, K. (3); Hovatta, O (2); Minthon, Lennart (2); Galasko, D (2); Zetterberg, Henrik, ... (2); Jonsson, B (2); Ekanayake, Chandima, ... (2); Westgren, M (2); Rosenquist, Richard (2); Inzunza, J (2); Hansson, Oskar (2); Curstedt, T. (2); Hallberg, B (2); Pratico, D (2); Iqbal, K (2); Olofsson, Erika (2); Malmgren, H (2); Heyman, Mats (2); Sahlen, S (2); Heinonen, Kristina (2); Sjögren, Magnus (2); Ewers, M. (2); Otto, M. (2); Borgström, Georg (2); visa färre...

Lärosäte: Karolinska Institutet (28); Göteborgs universitet (18); Lunds universitet (12); Uppsala universitet (6); Umeå universitet (3); Linköpings universitet (3); visa fler...; Chalmers tekniska högskola (3); Linnéuniversitetet (2); Jönköping University (1); visa färre...

Språk: Engelska (50); Svenska (2)

Forskningsämne (UKÄ/SCB): Medicin och hälsovetenskap (20); Naturvetenskap (5); Teknik (4); Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - Nationella bibliotekssystem
LIBRIS.kb.se

pil uppåt

Stäng

Kopiera och spara länken för att återkomma till aktuell vy